This video is the fifth in a five-part series that focuses on making sense of multiple myeloma treatment based upon the newly obtained input from the American Society of Hematology (ASH) in Orlando, FL.

Download Slides

Topics include:


with an educational grant from:
Amgen Oncology, Takeda Oncology, Janssen Oncology


Previous Post
Should I have an autologous stem cell transplant (ASCT)?
Next Post
CAR T therapy/Bi-specific T Cell engagers/MoAb: IMWG Conference Series ASH 2019 Orlando

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.